6190 — PhoenixBio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,014	1,325	2,124	1,715	1,541
Cost of Revenue
Gross Profit	588	728	1,556	1,195	1,118
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,290	1,757	1,616	1,705	1,961
Operating Profit	-277	-433	508	10	-420
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-224	-393	511	59.8	-433
Provision for Income Taxes
Net Income After Taxes	-238	-388	493	26.4	-449
Net Income Before Extraordinary Items
Net Income	-238	-388	493	26.4	-449
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-238	-388	493	26.4	-449
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-73.6	-65.3	97.4	7.09	-66.4
Dividends per Share